Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bioblast Pharma Ltd (NASDAQ:ORPN)

1.75
Delayed Data
As of 1:49pm ET
 -0.03 / -1.69%
Today’s Change
1.50
Today|||52-Week Range
7.95
-54.78%
Year-to-Date
No recent news for Bioblast Pharma Ltd.

Today’s Trading

Previous close1.78
Today’s open1.79
Day’s range1.75 - 1.80
Volume19,497
Average volume (3 months)108,183
Market cap$29.2M
Dividend yield--
Data as of 1:49pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-89.47%
Earnings growth (this year)+5.09%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
APTOAptose Biosciences I...-0.03-1.26%
PZRXPhaseRx Inc-0.17-6.88%
KDUSCadus Corp0.000.00%
CLBSCaladrius Bioscience...+0.18+3.85%
Data as of 1:41pm ET, 09/28/2016

Financials

Next reporting dateNovember 15, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$0.00
Annual profit (last year)-$15.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Fredric D. Price
Chief Financial Officer
Bob Cook
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Search for Jobs